Study shows rapamycin reverses myocardial defects in mouse model of LEOPARD syndrome
BOSTON — Congenital heart diseases affect approximately one in 100 patients, making them the most common type of birth defect and the number-one cause of pediatric deaths.
Now a new study showing that the mTOR inhibitor drug rapamycin can rev…